2021 Legislative Update: Week 8
Legislative Days 25 – 27
HB 653
HB 653, introduced by Representative Jasperse, allowing Pharmacists to order and administer COVID-19 tests, was first read in the House and was favorably reported via substitute out of the House Health and Human Services Committee in its last meeting before cross-over day, which is March 8.
The substitute allows pharmacists to order and administer COVID-19 testing, both serology (antibody) & viral (diagnostic), for a period of 12 months after the end of the federal emergency. This language is a result of a compromise with the understanding that we will continue discussions of this issue in the months to come should this legislation pass and become law.
While not ideal, from a public health perspective, this bill will ensure the public have broad access to COVID-19 testing from highly trained pharmacists, immediately after the federal emergency is over.
Even though this legislation was favorably reported, it has just one day to make it through the House Rules Committee, and then pass the House via a floor vote, so it has a ways to go in a short period of time.
By way of reminder, with regard to GPhA’s priority legislation, Senator Dean Burke’s SB 46 (Pharmacist administered adult ACIP recommended vaccines pursuant to protocol), this bill has already been passed by the Senate via substitute and awaits consideration by the House.
Previously Introduced Legislation
HB 316
Representative Stephens’ bill expanding pharmacist to technician ratio to 4-1, provided that 2 of the 4 technicians are certified, was favorably reported by the House Health and Human Services Committee and passed on the House floor. GPhA offered testimony in support.
HB 601
Representative Stephens bill removing Epidiolex as a Schedle V controlled substance was favorably reported by committee and passed the House in week 8.
HB 645
Representative Gravely’s legislation making changes to Georgia’s existing medical cannabis law was favorably reported by committee and passed the House. GPhA remains engaged in this legislation and seeking some small changes.
SB 80
Senator Kirkpatrick’s prior authorization legislation was passed by the Senate via substitute.
SB 92
Senator Robertson’s bill prohibiting the sale to and by minors of OTC drug products containing dextromethorphan was passed by the Senate.
